These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7724947)

  • 21. [Treatment of heart failure with beta-blockaders].
    Gundersen T; Dickstein K; Hole T; Kjekshus J; Myhre ES; Rønnevik P; Smith P; Westheim A
    Tidsskr Nor Laegeforen; 1997 Feb; 117(4):526-8. PubMed ID: 9148453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Beta-adrenergic blockers in congestive heart failure: pro et contra?].
    Trifunović SL; Pavlović K
    Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():44-50. PubMed ID: 18193810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Therapy and course of dilated cardiomyopathy].
    Hess OM; Greminger P; Maire R; Turina J; Krayenbühl HP
    Schweiz Med Wochenschr; 1985 May; 115(20):693-7. PubMed ID: 3892658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of infusions of different doses of dopamine in dilated cardiomyopathy. Observations during and after treatment with beta-blockers].
    Modena MG; Mattioli AV; Fantini G; Mattioli G
    Cardiologia; 1989 Jun; 34(6):531-6. PubMed ID: 2571414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Beta-adrenergic receptor blockers in the treatment of chronic heart failure].
    Mularek-Kubzdela T; Grajek S; Cieśliński A
    Pol Merkur Lekarski; 1996 Aug; 1(2):120-3. PubMed ID: 9156910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of beta-blockers in dilated cardiomyopathy.
    Waagstein F
    Curr Opin Cardiol; 1995 May; 10(3):322-31. PubMed ID: 7612984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Beta-blockers in cardiac insufficiency: should they always be considered in the therapeutic strategy? Arguments against].
    Ortigosa Aso J; Silva Melchor L; García A; de Artaza Andrade M
    Rev Esp Cardiol; 1997 May; 50(5):304-7. PubMed ID: 9281008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Beta-blocker therapy for chronic heart failure in patients with dilated cardiomyopathy].
    Hori M; Kagiya T; Sato H; Kitabatake A
    Kokyu To Junkan; 1990 Dec; 38(12):1203-9. PubMed ID: 1981100
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical use of beta-blockers in patients with heart failure.
    Eichhorn EJ
    J Card Fail; 2000 Jun; 6(2 Suppl 1):40-6. PubMed ID: 10908097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of cardiac insufficiency by beta-blockaders. A review of the literature and discussion].
    Hermida JS; Jarry G; Bertrand S; Guillaumont MP; Rey JL; Bernasconi P
    Ann Cardiol Angeiol (Paris); 1990 Feb; 39(2):103-7. PubMed ID: 1970467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Present day opinion about beta block treatment of congestive heart failure].
    Nessler J
    Przegl Lek; 1998; 55(12):669-72. PubMed ID: 10354719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beta-adrenergic receptor blockers as therapy in pediatric chronic heart failure.
    Shaddy RE
    Minerva Pediatr; 2001 Aug; 53(4):297-304. PubMed ID: 11573066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Normalization of ejection fraction and resolution of symptoms in chronic severe heart failure is possible with modern medical therapy: clinical observations in 11 patients.
    Harinstein ME; Berliner JI; Shah SJ; Taegtmeyer H; Gheorghiade M
    Am J Ther; 2008; 15(3):206-13. PubMed ID: 18496257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of beta-blockade with metoprolol on symptoms and functional capacity of patients with idiopathic dilated cardiomyopathy.
    Santostasi G; Marinato PG; Miraglia G; Egloff C; Maragno I
    Minerva Cardioangiol; 1994 Dec; 42(12):575-82. PubMed ID: 7753426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapy of idiopathic dilated cardiomyopathy with chronic beta-adrenergic blockade.
    Gilbert EM; O'Connell JB; Bristow MR
    Heart Vessels Suppl; 1991; 6():29-39. PubMed ID: 1687924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Heart failure with conserved systolic function. Therapeutic potential with beta blocking agents].
    Faggiano P; Rusconi C
    Ital Heart J Suppl; 2000 Aug; 1(8):1019-26. PubMed ID: 10993008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Drug therapy of cardiac insufficiency: status 1995].
    Rickenbacher P; Buser P; Osswald S; Pfisterer M
    Schweiz Med Wochenschr; 1996 May; 126(21):933-45. PubMed ID: 8693314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [New knowledge on the subject of therapy in cardiac decompensation in the light of large trials].
    Camerini F; Perkan A; Sinagra G; Di Lenarda A; Pinamonti B; Zecchin M
    Ann Ital Med Int; 1994 Oct; 9 Suppl():68S-77S. PubMed ID: 7857761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Temporal improvement in heart failure survival related to the use of a nurse-directed clinic and recommended pharmacological treatment.
    Andersson B; Kjörk E; Brunlöf G
    Int J Cardiol; 2005 Oct; 104(3):257-63. PubMed ID: 16186053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of growth hormone in chronic heart failure: therapeutic implications.
    Volterrani M; Giustina A; Manelli F; Cicoira MA; Lorusso R; Giordano A
    Ital Heart J; 2000 Nov; 1(11):732-8. PubMed ID: 11110515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.